Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 39% ± 18% | |
intestine | 12 studies | 39% ± 20% | |
kidney | 9 studies | 48% ± 20% | |
brain | 7 studies | 35% ± 17% | |
eye | 7 studies | 48% ± 21% | |
liver | 7 studies | 40% ± 12% | |
uterus | 6 studies | 50% ± 13% | |
lymph node | 5 studies | 37% ± 18% | |
prostate | 4 studies | 59% ± 20% | |
skin | 4 studies | 49% ± 17% | |
breast | 4 studies | 50% ± 17% | |
ovary | 3 studies | 41% ± 8% | |
heart | 3 studies | 23% ± 5% | |
adrenal gland | 3 studies | 43% ± 13% | |
esophagus | 3 studies | 38% ± 5% | |
pancreas | 3 studies | 40% ± 10% | |
stomach | 3 studies | 33% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 91% | 11781.47 | 224 / 245 | 100% | 229.49 | 500 / 502 |
esophagus | 95% | 10052.90 | 1379 / 1445 | 92% | 164.84 | 168 / 183 |
uterus | 93% | 11591.42 | 158 / 170 | 92% | 210.57 | 421 / 459 |
liver | 79% | 15307.49 | 179 / 226 | 99% | 168.77 | 401 / 406 |
kidney | 87% | 17871.61 | 77 / 89 | 86% | 67.90 | 779 / 901 |
lung | 78% | 26911.85 | 450 / 578 | 90% | 122.86 | 1040 / 1155 |
brain | 77% | 13928.81 | 2025 / 2642 | 90% | 92.10 | 638 / 705 |
thymus | 67% | 9632.74 | 437 / 653 | 94% | 75.53 | 568 / 605 |
breast | 61% | 3905.58 | 280 / 459 | 97% | 194.90 | 1088 / 1118 |
adrenal gland | 66% | 8539.96 | 169 / 258 | 88% | 95.33 | 202 / 230 |
bladder | 81% | 17192.86 | 17 / 21 | 69% | 105.81 | 348 / 504 |
skin | 53% | 3346.75 | 965 / 1809 | 96% | 121.30 | 455 / 472 |
ovary | 64% | 8457.07 | 116 / 180 | 82% | 99.52 | 351 / 430 |
intestine | 80% | 9940.40 | 770 / 966 | 63% | 68.76 | 332 / 527 |
stomach | 58% | 9403.79 | 210 / 359 | 63% | 53.61 | 181 / 286 |
pancreas | 29% | 3498.26 | 94 / 328 | 91% | 160.62 | 162 / 178 |
tonsil | 0% | 0 | 0 / 0 | 100% | 202.05 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 100.91 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 95% | 64.69 | 76 / 80 |
blood vessel | 94% | 9407.66 | 1254 / 1335 | 0% | 0 | 0 / 0 |
heart | 93% | 14403.75 | 802 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 82% | 25388.66 | 761 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 40.27 | 22 / 29 |
adipose | 73% | 9185.06 | 882 / 1204 | 0% | 0 | 0 / 0 |
spleen | 70% | 12329.32 | 168 / 241 | 0% | 0 | 0 / 0 |
muscle | 55% | 3697.02 | 439 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006986 | Biological process | response to unfolded protein |
GO_1903265 | Biological process | positive regulation of tumor necrosis factor-mediated signaling pathway |
GO_0046034 | Biological process | ATP metabolic process |
GO_1901029 | Biological process | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway |
GO_0070370 | Biological process | cellular heat acclimation |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0050821 | Biological process | protein stabilization |
GO_0070434 | Biological process | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO_0051085 | Biological process | chaperone cofactor-dependent protein refolding |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_1902236 | Biological process | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
GO_0007165 | Biological process | signal transduction |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0071383 | Biological process | cellular response to steroid hormone stimulus |
GO_0031396 | Biological process | regulation of protein ubiquitination |
GO_0051131 | Biological process | chaperone-mediated protein complex assembly |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0045648 | Biological process | positive regulation of erythrocyte differentiation |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0090084 | Biological process | negative regulation of inclusion body assembly |
GO_0034620 | Biological process | cellular response to unfolded protein |
GO_0007041 | Biological process | lysosomal transport |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0090063 | Biological process | positive regulation of microtubule nucleation |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0034605 | Biological process | cellular response to heat |
GO_0006402 | Biological process | mRNA catabolic process |
GO_0033120 | Biological process | positive regulation of RNA splicing |
GO_1901673 | Biological process | regulation of mitotic spindle assembly |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0042026 | Biological process | protein refolding |
GO_1902380 | Biological process | positive regulation of endoribonuclease activity |
GO_2001240 | Biological process | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO_0031397 | Biological process | negative regulation of protein ubiquitination |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005634 | Cellular component | nucleus |
GO_0005576 | Cellular component | extracellular region |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005814 | Cellular component | centriole |
GO_0008180 | Cellular component | COP9 signalosome |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005615 | Cellular component | extracellular space |
GO_0005739 | Cellular component | mitochondrion |
GO_0005813 | Cellular component | centrosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0016234 | Cellular component | inclusion body |
GO_0072562 | Cellular component | blood microparticle |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005737 | Cellular component | cytoplasm |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016607 | Cellular component | nuclear speck |
GO_0005925 | Cellular component | focal adhesion |
GO_0005829 | Cellular component | cytosol |
GO_0031982 | Cellular component | vesicle |
GO_0016235 | Cellular component | aggresome |
GO_0051787 | Molecular function | misfolded protein binding |
GO_0048018 | Molecular function | receptor ligand activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0001618 | Molecular function | virus receptor activity |
GO_0001664 | Molecular function | G protein-coupled receptor binding |
GO_0005524 | Molecular function | ATP binding |
GO_0140545 | Molecular function | ATP-dependent protein disaggregase activity |
GO_0044183 | Molecular function | protein folding chaperone |
GO_0140416 | Molecular function | transcription regulator inhibitor activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0055131 | Molecular function | C3HC4-type RING finger domain binding |
GO_0031072 | Molecular function | heat shock protein binding |
GO_0003723 | Molecular function | RNA binding |
GO_0031249 | Molecular function | denatured protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0038177 | Molecular function | death receptor agonist activity |
GO_0045296 | Molecular function | cadherin binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0140662 | Molecular function | ATP-dependent protein folding chaperone |
GO_0097718 | Molecular function | disordered domain specific binding |
Gene name | HSPA1A |
Protein name | Heat shock 70 kDa protein 1A (Heat shock protein family A (Hsp70) member 1A) Heat shock 70 kDa protein 1A (Heat shock 70 kDa protein 1) (HSP70-1) (HSP70.1) Epididymis secretory protein Li 103 (Epididymis secretory sperm binding protein) (HSPA1A) (HSPA1B) (Heat shock 70kDa protein 1A) (Heat shock 70kDa protein 1B) |
Synonyms | hCG_1820593 HEL-S-103 HSPA1B HSX70 hCG_43726 HSP72 HSPA1 |
Description | FUNCTION: Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The co-chaperones have been shown to not only regulate different steps of the ATPase cycle, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. The co-chaperones are of three types: J-domain co-chaperones such as HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-bound state thereby promoting substrate release), and the TPR domain chaperones such as HOPX and STUB1 . Maintains protein homeostasis during cellular stress through two opposing mechanisms: protein refolding and degradation. Its acetylation/deacetylation state determines whether it functions in protein refolding or protein degradation by controlling the competitive binding of co-chaperones HOPX and STUB1. During the early stress response, the acetylated form binds to HOPX which assists in chaperone-mediated protein refolding, thereafter, it is deacetylated and binds to ubiquitin ligase STUB1 that promotes ubiquitin-mediated protein degradation . Regulates centrosome integrity during mitosis, and is required for the maintenance of a functional mitotic centrosome that supports the assembly of a bipolar mitotic spindle . Enhances STUB1-mediated SMAD3 ubiquitination and degradation and facilitates STUB1-mediated inhibition of TGF-beta signaling . Essential for STUB1-mediated ubiquitination and degradation of FOXP3 in regulatory T-cells (Treg) during inflammation . Required as a co-chaperone for optimal STUB1/CHIP ubiquitination of NFATC3 (By similarity). Negatively regulates heat shock-induced HSF1 transcriptional activity during the attenuation and recovery phase period of the heat shock response . Involved in the clearance of misfolded PRDM1/Blimp-1 proteins. Sequesters them in the cytoplasm and promotes their association with SYNV1/HRD1, leading to proteasomal degradation . .; FUNCTION: (Microbial infection) In case of rotavirus A infection, serves as a post-attachment receptor for the virus to facilitate entry into the cell. . |
Accessions | ENST00000375651.7 [P0DMV8-1] ENST00000449876.1 ENST00000452298.1 ENST00000400040.1 P0DMV8 ENST00000383389.2 A8K5I0 ENST00000422919.1 ENST00000608703.1 V9GZ37 ENST00000430065.1 [P0DMV8-1] ENST00000441618.1 [P0DMV8-1] ENST00000433487.1 [P0DMV8-1] |